Skip to main content
Premium Trial:

Request an Annual Quote

Fluxion ERASE-Seq NGS Liquid Biopsy Analysis Service

Fluxion Biosciences said that its ERASE-Seq bioinformatics solution can now be used for variant calling from a wide range of targeted cancer panels. The analysis tool was previously limited to use on Fluxion's Spotlight 59 cancer panel. Users can now apply ERASE-Seq to Swift Biosciences' Accel Amplicon 56G panel and Illumina's TruSight Tumor 15 panel using bioinformatic analyses that are already cloud accessible. Other custom and commercial panels that customers may be interested in can also be added following validation testing by Fluxion, the company said.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.